Cellular mechanism of Arid1b haploinsufficiency-associated social deficit
Arid1b单倍体不足相关的社会缺陷的细胞机制
基本信息
- 批准号:10736386
- 负责人:
- 金额:$ 55.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:ARID DomainARID1A geneATP Synthesis PathwayAnimal ModelAreaAxonBehaviorBehavior ControlBehavior DisordersBehavioralBiochemicalBiogenesisBiological AssayBrainCellsChildComplementComplexDataDefectDevelopmentDopamineElectron TransportElectrophysiology (science)FOS geneFoundationsFragile X SyndromeFunctional disorderGene Expression AlterationGenesGeneticGenetic studyGlutathioneGoalsHumanImpairmentIndividualIntellectual functioning disabilityInvestigationLabelLinkMediatingMessenger RNAMidbrain structureMitochondriaModelingMolecularMusNeurodevelopmental DisorderNeuronsNeuropathogenesisNucleus AccumbensOxidative StressOxygen ConsumptionPathogenicityPathologicPathway interactionsPatientsPhenotypePhysiologyPlayPreventionPrevention strategyProductionReactive Oxygen SpeciesReportingRewardsRiboTagRoleSamplingSeveritiesSocial BehaviorSocial InteractionSynapsesTestingTranscription ElongationTranscriptional RegulationVentral Tegmental AreaVirusautism spectrum disorderautistic childrenbehavioral impairmentcell typedata modelingdopaminergic neuronhuman modelimprovedinduced pluripotent stem cellinsightmitochondrial dysfunctionmouse geneticsmouse modelnerve supplyneurodevelopmentneuropathologynoveloptogeneticsoverexpressionpharmacologicpreferencepromoterrepetitive behaviorrespiratory enzymeresponsesingle-cell RNA sequencingsocialsocial communicationsocial deficitstherapeutic developmenttooltranscription factortreatment strategy
项目摘要
Project Summary
Autism spectrum disorder (ASD) is characterized by impaired social interaction and communication as well as
repetitive behavior. While ASD behaviors are well described, the pathological mechanism underlying this
developmental condition remains unknown. There are no pharmacological and/or genetic preventions or cures
for ASD. Development of therapeutic tools requires identification of causative factors and their cellular
mechanisms in the brain. Recent genetic studies have shown that haploinsufficiency of the AT-rich interactive
domain 1B (ARID1B) gene causes ASD and intellectual disability, suggesting that ARID1B may play a critical
role in social behavior control. Although ARID1B haploinsufficiency reportedly causes ASD, nothing was known
about how ARID1B dysfunction leads to abnormal social behavior in ASD. In response to this challenge, we
generated a mouse model of ARID1B haploinsufficiency and found that this mouse displays social deficits
recapitulating human ASD phenotypes. Our goal is to identify the cellular mechanism of ARID1B
haploinsufficiency-induced social deficits. Prior studies show that the brain circuit between the ventral tagmental
area (VTA) and nucleus accumbens (NAc) regulates social behavior. They also present a strong link between
ASD and mitochondrial defects. Furthermore, studies suggest an association of Arid1b haploinsufficiency with
mitochondrial dysfunction. In our preliminary investigation, we found that the VTA-to-NAc connection was
reduced in Arid1b haploinsufficient mice compared to wild-type controls. Additionally, we observed functional
alterations of mitochondria and overproduction of reactive oxygen species in the Arid1b mouse model of ASD.
Mitochondria-associated genes were downregulated in the Arid1b model. Based on our preliminary findings
combined with previous studies, we hypothesize that disturbance in the VTA-NAc circuit plays a key role in
social deficits in Arid1b haploinsufficient mice and that mitochondrial defects underlie the social alteration.
Using a combination of mouse genetics, virus-mediated circuit manipulation, electrophysiological assessment,
human iPSC investigation, and molecular/biochemical approaches, we will test these ideas in mouse and
human models by examining the following related aims: Aim 1) Examine the role of the mesolimbic circuit in
social behavior in Arid1b haploinsufficient mice; Aim 2) Examine mitochondrial dysfunction as a cellular
mechanism of Arid1b haploinsufficiency-induced mesolimbic abnormality; Aim 3) Identify the molecular
mechanism underlying mitochondrial dysfunction in Arid1b haploinsufficiency. Our study may provide novel
mechanistic insights into social deficits in ASD related to brain circuit alteration and mitochondrial dysfunction.
项目概要
自闭症谱系障碍 (ASD) 的特点是社交互动和沟通受损以及
重复的行为。虽然 ASD 行为已得到很好的描述,但其背后的病理机制
发育状况仍未知。没有药物和/或遗传预防或治疗方法
对于自闭症谱系障碍。治疗工具的开发需要识别致病因素及其细胞
大脑中的机制。最近的遗传学研究表明,富含 AT 的相互作用的单倍体不足
结构域 1B (ARID1B) 基因导致 ASD 和智力障碍,表明 ARID1B 可能发挥关键作用
在社会行为控制中的作用。尽管据报道 ARID1B 单倍体不足会导致自闭症谱系障碍 (ASD),但我们对此一无所知
关于 ARID1B 功能障碍如何导致自闭症谱系障碍 (ASD) 患者的异常社会行为。为了应对这一挑战,我们
建立了 ARID1B 单倍体不足的小鼠模型,并发现这只小鼠表现出社交缺陷
概括人类 ASD 表型。我们的目标是确定 ARID1B 的细胞机制
单倍体不足引起的社会缺陷。先前的研究表明,腹侧标签之间的大脑回路
区(VTA)和伏隔核(NAc)调节社会行为。它们还呈现出之间的紧密联系
ASD 和线粒体缺陷。此外,研究表明 Arid1b 单倍体不足与
线粒体功能障碍。在我们的初步调查中,我们发现 VTA 到 NAc 的连接是
与野生型对照相比,Arid1b 单倍体不足的小鼠中的减少。此外,我们观察到功能
Arid1b 小鼠自闭症谱系障碍模型中线粒体的改变和活性氧的过量产生。
线粒体相关基因在 Arid1b 模型中下调。根据我们的初步调查结果
结合之前的研究,我们假设 VTA-NAc 回路中的干扰在
Arid1b 单倍体不足的小鼠存在社交缺陷,线粒体缺陷是社交改变的基础。
结合小鼠遗传学、病毒介导的电路操作、电生理评估、
人类 iPSC 研究和分子/生化方法,我们将在小鼠和
通过检查以下相关目标的人体模型: 目标 1) 检查中脑边缘回路在
Arid1b 单倍体不足小鼠的社会行为;目标 2) 检查线粒体功能障碍作为细胞
Arid1b单倍体不足引起中脑边缘异常的机制;目标 3) 识别分子
Arid1b 单倍体不足导致线粒体功能障碍的机制。我们的研究可能会提供新颖的
对自闭症谱系障碍中与脑回路改变和线粒体功能障碍相关的社会缺陷的机制见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Woo-Yang Kim其他文献
Woo-Yang Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Woo-Yang Kim', 18)}}的其他基金
Functional Characterization of a Causative Gene for Intellectual Disability
智力障碍致病基因的功能表征
- 批准号:
9015785 - 财政年份:2015
- 资助金额:
$ 55.71万 - 项目类别:
相似国自然基金
基于类器官模型的ARID1A基因功能失活在膀胱癌发生发展中的作用及相关分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
ARID1A基因突变在NSCLC免疫治疗中的作用机制及其临床应用价值探索
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
染色质重塑基因Arid1a缺失促进肝细胞向肝内胆管癌恶性转化的分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
激酶抑制剂文库筛选鉴定靶向治疗ARID1A基因缺陷型结直肠癌的协同致死因子及分子机制研究
- 批准号:82172638
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
ARID1A基因变异与胆道癌循环肿瘤细胞表型、上皮间质转化的关系
- 批准号:
- 批准年份:2021
- 资助金额:54.7 万元
- 项目类别:面上项目
相似海外基金
ARID1a and Chromatin Landscape in Pulmonary Vascular Disease
ARID1a 和肺血管疾病中的染色质景观
- 批准号:
10727052 - 财政年份:2023
- 资助金额:
$ 55.71万 - 项目类别:
Transcriptional-translational conflict in bladder epithelial homeostasis and cancer
膀胱上皮稳态和癌症中的转录-翻译冲突
- 批准号:
10564590 - 财政年份:2023
- 资助金额:
$ 55.71万 - 项目类别:
Identifying and targeting collateral lethal vulnerabilities in cancers
识别并针对癌症的附带致命弱点
- 批准号:
10563469 - 财政年份:2023
- 资助金额:
$ 55.71万 - 项目类别:
Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
胰腺癌中 KRAS 抑制的反应和耐药机制
- 批准号:
10566224 - 财政年份:2023
- 资助金额:
$ 55.71万 - 项目类别:
Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities
阐明新的 WNT4 调节轴作为妇科癌症健康差异的驱动因素
- 批准号:
10773991 - 财政年份:2023
- 资助金额:
$ 55.71万 - 项目类别: